FluGen Inc. is developing a more effective vaccine in the fight against influenza and respiratory disease, specifically through its M2SR Vaccine Platform.

FluGen Inc.

FLUGEN, INC. | 364 followers on LinkedIn. Transforming vaccine efficacy in respiratory disease. | FluGen, Inc. is a clinical-stage vaccine company transforming vaccine efficacy in respiratory diseases.

Erik Iverson

FLUGEN, INC.

FluGen's M2SR in Lancet ID today showing superior resposne when combined with Fluzone High Dose in older adults versus Fluzone High Dose alone ( https://lnkd.in/gnchM5-x ) This could be a big improvement in preventing flu morbidity and mortality in older adults bit.ly/3S3gvMC

FLUG

COM:FLUGEN

FluGen Inc.